Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Spinal trigeminal nucleus is a large sensory nucleus in the brainstem that receives primary afferent fibers from the trigeminal nerve (Cranial Nerve V) (StatPearls, 2023). It is functionally divided into three subnuclei: pars oralis, pars interpolaris, and pars caudalis, with the pars caudalis being the primary site for processing pain and temperature information from the face and head (NIH, 2022). This region serves as a critical relay station in the trigeminovascular system, making it a focal point for the pathophysiology of primary headaches like migraine and neuropathic conditions like trigeminal neuralgia (PubMed, 2021). While not a single molecular target itself, it contains numerous receptors (e.g., CGRP receptors, 5-HT1B/1D receptors) and ion channels that are targeted by analgesics and anti-migraine medications (Journal of Headache and Pain, 2020). Therapeutic intervention in this area aims to dampen the hyperexcitability of second-order neurons to alleviate chronic or acute craniofacial pain.
Modulation of neurotransmission (e.g., inhibition of CGRP release or blockade of voltage-gated sodium channels) within the brainstem to reduce nociceptive signaling from the trigeminal nerve.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spinal trigeminal nucleus (Sp5).